Your SlideShare is downloading. ×
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
AP02: Amgen, Inc.: The No-Impact Migration –  Upgrades in a Validated Environment
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

AP02: Amgen, Inc.: The No-Impact Migration – Upgrades in a Validated Environment

410

Published on

Safe production of cutting-edge biopharmaceuticals relies on advanced manufacturing technology. At its Thousand Oaks, California facility, Amgen develops and manufactures innovative human …

Safe production of cutting-edge biopharmaceuticals relies on advanced manufacturing technology. At its Thousand Oaks, California facility, Amgen develops and manufactures innovative human therapeutics, but needed to update legacy control systems to keep up with production demands. Through a series of scheduled phases, Amgen migrated to a new control system with a centralized
architecture in a validated environment without effecting ongoing operations. Virtualized servers helped reduce cost and impact of the transition.

Published in: Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
410
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
15
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Copyright © 2014 Rockwell Automation, Inc. All Rights Reserved. PUBLIC INFORMATION Amgen, Inc.: The No-Impact Migration - Upgrades in a Validated Environment
  • 2. Innovative Strategies in Migrating Legacy PLC5 Control Systems Tom Lopez, Amgen Richard Kleinfeld, M+W Automation
  • 3. Agenda • Company Background • CEMS Implementation • UCS Implementation • Q & A
  • 4. Amgen  Today World’s largest independent  biotechnology company ~ 20,000 employees > 75 countries Reached millions of patients
  • 5. For additional information about Amgen products, including important safety information, please visit amgen.com; Kyprolis® (carfilzomib) is developed and marketed (except in Japan) by Onyx  Pharmaceuticals, an Amgen subsidiary; NEXAVAR® (sorafenib) is developed and marketed under collaboration and co‐promotion agreements between Bayer Healthcare and Onyx Pharmaceuticals
  • 6. M+W Automation (MWA) Competence Network AMERICAS EUROPE ASIA/PACIFIC 270 Employees Headquarters: • Danbury, CT, USA 630 Employees Headquarters: • Ludwigshafen, Germany 60 Employees Headquarters: • Shanghai, China • Austria • Belgium • Czech Republic • Germany • Ireland • Poland • Russia • Switzerland • Slovakia • The Netherlands • Turkey • Canada • Puerto Rico • USA  Chemicals  Pharma & Biotech  Food & Nutrition  Automotive  Semiconductor  Oil & Gas, Mining Industries
  • 7. Background: • Critical Equipment Monitoring System (CEMS) • Windows 2000 Upgrades initiated discussions for strategic review/replacement of obsolete hardware/software 7 CEMS Implementation
  • 8. 8 CEMS Implementation Background: • Main Buildings in scope (I/O count): • BA (120) • BB (45) • BC (80) • BD (240) • BE (720) • BF (180) • BG (200) • BH (690) Total Buildings Upgraded: 11 Total I/O: 2615 • Other Buildings/Sites: • BI (300) • SiteJ (45)
  • 9. 9 CEMS Implementation Business Case Detailed Design Implementation /Testing Commissioning Traditional New Design Benefits Stand-Alone Installations Rockwell Client-Server- architecture Fully integrated design, Centralized software, Ease of maintenance/ change management iFix HMI – Rockwell PLC integration Rockwell HMI – Rockwell PLC Amgen standard, Ease of integration, minimize training/ customization between vendors iFix Data Collection/ Trending PI Interfaces for each building Amgen standard, more robust & reduce complexity/SPOF
  • 10. 10 CEMS Implementation Business Case Detailed Design Implementation /Testing Commissioning Traditional New Design Benefits iFix-based Alarm Generation PLC-based Alarm Generation More robust & reduce complexity Custom HMI design Rockwell GEMS library Amgen standard, Rockwell COTS support Win911 and HMI on common workstation HMI on Server Win911 on workstation Dedicated workstation for Alarm Notification Automation Hardware on business network (VLAN) Automation Hardware on Manufacturing Network Secure, dedicated network for automation assets limits exposure to threats Innovation and best practices helped drive our strategy
  • 11. 11 CEMS Implementation • GMAX contract (i.e. T&M Not Too Exceed) • Competitively Bid • Leverage a Bundled Approach • Drive Savings Business Case Detailed Design Implementation /Testing Commissioning
  • 12. 12 CEMS Implementation Business Case Detailed Design Implementation /Testing Commissioning • Leverage common documents for multiple buildings • URS, FS, NDS, OIDS • Generate site/building-specific documents • SDS, DT, IV/OV, RTM, VSR
  • 13. Software Builds: CEMS Implementation
  • 14. CEMS Implementation GEMS Library:
  • 15. 15 CEMS Project Implementation Business Case Detailed Design Implementation /Testing Commissioning • Module Configuration Tool • Tag Rung Tool • Document Development Tool • Development Test in Parallel with live system • Development System on VM Environment • Mobile PLC for Parallel Communication
  • 16. Module Configuration Tool: CEMS Project Implementation
  • 17. Tag Rung Tool: CEMS Project Implementation
  • 18. CEMS Project Implementation Document Development:
  • 19. CEMS Project Implementation
  • 20. 20 CEMS Implementation Business Case Detailed Design Implementation /Testing Commissioning • Software tools developed, translate design docs to commissioning docs • Minimal Validation Requirements • Minimal Downtime • I/O Wiring Conversion
  • 21. I/O Wiring Conversion: CEMS Implementation
  • 22. • What is Virtualization? 22 UCS Implementation
  • 23. 23 • Benefits: • Less Physical Infrastructure to Maintain • High Application Availability • Stable System Modifications • Lifecycle costs • Risks: • Network Issues • Software/Application Compatibility • VMWare Robustness • Novel technology UCS Implementation
  • 24. 24 UCS Implementation
  • 25. Project Results • CEMS downtime required for startup 4 hours. • On time under budget for 8 consecutive startup scheduled 1 month apart • Solution can perform JackPanel functions with no invasive action • Automation solution is on a segregated Manufacturing Network • Maintenance cost reduced • 30% Cost Avoidance/Savings from Original Estimate
  • 26. Questions? Tom Lopez, Amgen Richard Kleinfeld, M+W Automation
  • 27. Copyright © 2014 Rockwell Automation, Inc. All Rights Reserved. We care what you think!  On the mobile app: 1. Locate session using Schedule or Agenda Builder 2. Click on the thumbs up icon on the lower right corner of the session detail 3. Complete survey 4. Click the Submit Form button 27 Please take a couple minutes to complete a quick session survey to tell us how we’re doing. 2 3 4 1 Thank you!!
  • 28. Copyright © 2014 Rockwell Automation, Inc. All Rights Reserved. www.rsteched.com Follow RSTechED on Facebook & Twitter. Connect with us on LinkedIn. PUBLIC INFORMATION Thank you for attending our session!

×